CYCN / Cyclerion Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Cyclerion Therapeutics, Inc.
US ˙ NasdaqCM ˙ US23255M2044

Deler fremragende 4,241,260 shares
Insideraktier837.429 shares
Insider ejerskab19,74 %
Total Insiders25
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )
4876 out of 10951

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000% ( )
4845 out of 10791

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Cyclerion Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Andreas Busch Chief Innovation Officer - [O] 254.704 12.735
Chicko Rhonda M. Chief Financial Officer - [O] 18 18
George H Conrades Director - [D] 4.334 217
Kevin Churchwell Director - [D] 2.421 121
Gina Consylman 0
Mark G Currie President and CSO - [O] 251.648 12.582
Errol B Desouza Director - [D] 30.000 30.000
Marsha Fanucci Director - [D] 16.950 848
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Cheryl Gault Chief Operating Officer - [O] 794 40
Anjeza Gjino Chief Financial Officer - [O] 31.599 1.580
Regina Margaret Graul President - [O] 100.303 100.303
David Gerald Greenspan 10% Owner - [10%] 7.157.601 0
Peter M Hecht Director, 10% Owner - [D] [10%] 559.275 559.275
Michael J Higgins Director - [D] 30.740 30.740
William Huyett Chief Financial Officer - [O] 67.590 3.380
Steven Hyman Director - [D] 20.000 20.000
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Ironwood Pharmaceuticals Inc 10% Owner - [10%] 0 0
Ole Isacson Director - [D] 2.421 121
Dina Katabi Director - [D] 20.000 20.000
Stephanie Lovell Director - [D] 2.421 121
Terrance Mcguire Director - [D] 42.010 42.010
Michael Mendelsohn Director - [D] 2.421 121
Amy W Schulman Director - [D] 21.635 1.082
Slate Path Capital LP 10% Owner - [10%] 0 0
Christopher I Wright Chief Medical Officer - [O] 42.728 2.136

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CYCN / Cyclerion Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2021-06-03 Slate Path Capital LP 961.538 3,1200 48.077 62,4000 2.999.999 11 1716 79.498.418 2.649,95
2021-06-03 MCGUIRE TERRANCE 92.831 3,1200 4.642 62,4000 289.633
2021-06-03 MCGUIRE TERRANCE 3.322 3,1200 166 62,4000 10.365
2021-06-03 Hecht Peter M 823.170 3,2800 41.158 65,6000 2.699.998
2021-05-06 Hecht Peter M 302.000 2,4300 15.100 48,6000 733.860
2021-05-05 Hecht Peter M 398.001 2,5300 19.900 50,6000 1.006.943
2021-05-04 Hecht Peter M 300.000 2,2900 15.000 45,8000 687.000
2020-11-09 Busch Andreas 125.000 2,5300 6.250 50,6000 316.250
2019-11-15 Busch Andreas 125.000 1,8200 6.250 36,4000 227.500

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CYCN / Cyclerion Therapeutics, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CYCN / Cyclerion Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2024-11-21 Slate Path Capital LP 357.880 1,5511 357.880 1,5511 555.108 5 1.3600 -68.390 -12,32
2023-08-09 MCGUIRE TERRANCE 8 3,3950 8 3,3950 27
2020-12-28 Currie Mark G 20.107 3,0100 1.005 60,2000 60.522
2019-12-30 Currie Mark G 25.000 2,4800 1.250 49,6000 62.000
2019-12-27 Currie Mark G 25.000 2,5500 1.250 51,0000 63.750

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CYCN / Cyclerion Therapeutics, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2025-03-27 2025-03-25 4 Hecht Peter M CYCN Common Stock A - Award D 2,7500 181.818 500 559.203
2025-03-27 2025-03-25 4 Higgins Michael J CYCN Common Stock A - Award D 2,7500 9.090 25 30.740
2024-11-25 2024-11-21 4 Slate Path Capital LP CYCN Common Stock, no par value S - Sale I 1,5511 -357.880 -555 0
2024-03-11 3 CHICKO RHONDA M. CYCN Common Stock D 18
2024-01-26 2024-01-01 4 Hecht Peter M CYCN Common Stock A - Award D 15.000 377.385
2024-01-26 2024-01-01 4 Graul Regina Margaret CYCN Common Stock A - Award D 50.000 100.303
2023-12-11 3 Katabi Dina CYCN Common Stock D 20.000
2023-12-07 3/A Graul Regina Margaret CYCN Common Stock D 50.303
2023-12-07 3 Higgins Michael J CYCN Common Stock D 21.650
2023-12-04 2023-11-30 4 DESOUZA ERROL B CYCN Common Stock A - Award D 30.000 30.000
2023-12-04 2023-11-30 4 DESOUZA ERROL B CYCN Common Stock A - Award D 20.000 50.000
2023-12-04 2023-12-01 4 Hecht Peter M CYCN Common Stock A - Award D 15.000 362.385
2023-12-04 2023-11-30 4 Hecht Peter M CYCN Common Stock A - Award D 20.000 347.385
2023-12-04 2023-11-30 4 MCGUIRE TERRANCE CYCN Common Stock A - Award D 5.000 5.552
2023-12-04 3 Graul Regina Margaret CYCN Common Stock D 50.000
2023-12-04 2023-11-30 4 Hyman Steven CYCN Common Stock A - Award D 20.000 20.000
2023-08-11 2023-08-09 4 MCGUIRE TERRANCE By Polaris Venture Management Co. II, L.L.C. CYCN Common Stock S - Sale I 3,3950 -8 -0 0
2023-05-22 2023-05-19 4 Hecht Peter M CYCN Common Stock A - Award D 8,6800 225.000 1.953 327.385
2022-07-26 3 Hyman Steven CYCN Common Stock D 0
2022-01-24 2022-01-20 4 Busch Andreas CYCN Employee Stock Option (Right to Buy) A - Award D 1,21 135.000 135.000
2022-01-24 2022-01-20 4 Gjino Anjeza CYCN Employee Stock Option (Right to Buy) A - Award D 1,21 135.000 135.000
2022-01-24 2022-01-20 4 Hecht Peter M CYCN Employee Stock Option (Right to Buy) A - Award D 1,21 430.000 430.000
2022-01-24 2022-01-03 4 Hecht Peter M CYCN Employee Stock Option (Right to Buy) A - Award D 1,78 52.950 52.950
2022-01-24 2022-01-20 4 Gault Cheryl CYCN Employee Stock Option (Right to Buy) A - Award D 1,21 135.000 135.000
2021-12-10 2021-12-09 4 Gault Cheryl CYCN Employee Stock Option (Right to Buy) A - Award D 1,93 100.000 100.000
2021-12-10 2021-12-09 4 Gjino Anjeza CYCN Employee Stock Option (Right to Buy) A - Award D 1,93 100.000 100.000
2021-12-10 2021-12-09 4 Busch Andreas CYCN Employee Stock Option (Right to Buy) A - Award D 1,93 75.000 75.000
2021-06-28 2021-06-24 4 Lovell Stephanie CYCN Stock Option (Right to Buy) A - Award D 3,97 10.000 10.000
2021-06-28 2021-06-24 4 Fanucci Marsha CYCN Stock Option (Right to Buy) A - Award D 3,97 10.000 10.000
2021-06-28 2021-06-24 4 Isacson Ole CYCN Stock Option (Right to Buy) A - Award D 3,97 10.000 10.000
2021-06-28 2021-06-24 4 Churchwell Kevin CYCN Stock Option (Right to Buy) A - Award D 3,97 10.000 10.000
2021-06-28 2021-06-24 4 Mendelsohn Michael CYCN Stock Option (Right to Buy) A - Award D 3,97 10.000 10.000
2021-06-28 2021-06-24 4 CONRADES GEORGE H CYCN Stock Option (Right to Buy) A - Award D 3,97 10.000 10.000
2021-06-28 2021-06-24 4 DESOUZA ERROL B CYCN Stock Option (Right to Buy) A - Award D 3,97 10.000 10.000
2021-06-28 2021-06-24 4 MCGUIRE TERRANCE CYCN Stock Option (Right to Buy) A - Award D 3,97 10.000 10.000
2021-06-07 2021-06-03 4 MCGUIRE TERRANCE By Polaris Entrepreneurs' Fund VIII, L.P. CYCN Common Stock P - Purchase I 3,1200 3.322 10 24.957
2021-06-07 2021-06-03 4 MCGUIRE TERRANCE By Polaris Partners VIII, L.P. CYCN Common Stock P - Purchase I 3,1200 92.831 290 697.313
2021-06-07 2021-06-03 4 Hecht Peter M CYCN Common Stock P - Purchase D 3,2800 823.170 2.700 2.047.698
2021-06-07 2021-06-03 4 Slate Path Capital LP CYCN Common Stock, no par value P - Purchase I 3,1200 961.538 3.000 7.157.601
2021-05-19 3 DESOUZA ERROL B CYCN Common Stock D 0
2021-05-10 2021-05-06 4 Hecht Peter M CYCN Common Stock P - Purchase D 2,4300 302.000 734 1.224.528
2021-05-06 2021-05-05 4 Hecht Peter M CYCN Common Stock P - Purchase D 2,5300 398.001 1.007 922.528
2021-05-06 2021-05-04 4 Hecht Peter M CYCN Common Stock P - Purchase D 2,2900 300.000 687 524.527
2021-03-01 2021-02-25 4 Gjino Anjeza CYCN Common Stock S - Sale D 4,0000 -1.824 -7 31.599
2021-03-01 2021-02-25 4 Wright Christopher I CYCN Common Stock S - Sale D 3,9900 -2.637 -11 42.728
2021-01-11 3 Gjino Anjeza CYCN Common Stock D 15.224
2021-01-11 3 Gjino Anjeza CYCN Common Stock D 18.199
2021-01-11 3 Gault Cheryl CYCN Common Stock D 8.500
2021-01-11 3 Gault Cheryl CYCN Common Stock D 794
2020-12-30 3 Wright Christopher I [CYCN] Common Stock D 17.009
2020-12-30 3 Wright Christopher I [CYCN] Common Stock D 28.356
2020-12-30 2020-12-28 4 Currie Mark G CYCN Common Stock S - Sale D 3,0100 -20.107 -61 251.648
2020-11-12 2020-11-09 4 Busch Andreas CYCN Common Stock P - Purchase D 2,5300 125.000 316 254.704
2020-11-10 2020-11-06 4 Huyett William CYCN Common Stock S - Sale D 2,5200 -3.827 -10 67.590
2020-11-06 2020-11-04 4 Busch Andreas CYCN Employee Stock Option (Right to Buy) A - Award D 2,48 75.000 75.000
2020-08-10 3 Greenspan David Gerald CYCN Common Stock, no par value I 12.392.126
2020-08-10 3 Greenspan David Gerald CYCN Common Stock, no par value I 12.392.126
2020-08-10 3 Greenspan David Gerald CYCN Common Stock, no par value I 12.392.126
2020-08-10 3 Greenspan David Gerald CYCN Common Stock, no par value I 12.392.126
2020-06-18 2020-06-16 4 SCHULMAN AMY W CYCN Stock Option (Right to Buy) A - Award D 4,46 10.000 10.000
2020-06-18 2020-06-16 4 Mendelsohn Michael CYCN Stock Option (Right to Buy) A - Award D 4,46 10.000 10.000
2020-06-18 2020-06-16 4 MCGUIRE TERRANCE CYCN Stock Option (Right to Buy) A - Award D 4,46 10.000 10.000
2020-06-18 2020-06-16 4 Lovell Stephanie CYCN Stock Option (Right to Buy) A - Award D 4,46 10.000 10.000
2020-06-18 2020-06-16 4 Isacson Ole CYCN Stock Option (Right to Buy) A - Award D 4,46 10.000 10.000
2020-06-18 2020-06-16 4 Fanucci Marsha CYCN Stock Option (Right to Buy) A - Award D 4,46 10.000 10.000
2020-06-18 2020-06-16 4 CONRADES GEORGE H CYCN Stock Option (Right to Buy) A - Award D 4,46 10.000 10.000
2020-06-18 2020-06-16 4 Churchwell Kevin CYCN Stock Option (Right to Buy) A - Award D 4,46 10.000 10.000
2020-04-02 2020-03-31 4 Hecht Peter M CYCN Employee Stock Option (Right to Buy) A - Award D 2,65 2,6500 153.846 408 153.846
2020-02-25 2020-02-21 4 Huyett William CYCN Common Stock S - Sale D 5,1200 -3.559 -18 71.417
2019-12-31 2019-12-30 4 Currie Mark G CYCN Common Stock S - Sale D 2,4800 -25.000 -62 271.755
2019-12-31 2019-12-27 4 Currie Mark G CYCN Common Stock S - Sale D 2,5500 -25.000 -64 296.755
2019-11-26 2019-11-22 4 Busch Andreas CYCN Employee Stock Option (Right to Buy) A - Award D 2,01 75.000 75.000
2019-11-26 2019-11-22 4 Huyett William CYCN Employee Stock Option (Right to Buy) A - Award D 2,01 75.000 75.000
2019-11-26 2019-11-22 4 Currie Mark G CYCN Employee Stock Option (Right to Buy) A - Award D 2,01 75.000 75.000
2019-11-26 2019-11-22 4 Hecht Peter M CYCN Employee Stock Option (Right to Buy) A - Award D 2,01 75.000 75.000
2019-11-19 2019-11-15 4 Busch Andreas CYCN Common Stock P - Purchase D 1,8200 125.000 228 125.000
2019-11-12 2019-11-08 4 Huyett William CYCN Common Stock S - Sale D 2,0500 -3.922 -8 74.976
2019-09-20 2019-04-01 4/A Huyett William CYCN Employee Stock Option (Right to Buy) A - Award D 14,21 221.964 221.964
2019-09-20 2019-04-01 4/A Huyett William CYCN Employee Stock Option (Right to Buy) A - Award D 16,82 221.312 221.312
2019-09-20 2019-04-01 4/A Huyett William CYCN Common Stock A - Award D 39.172 78.898
2019-09-20 2019-04-01 4/A Huyett William CYCN Common Stock A - Award D 38.320 38.320
2019-09-20 2019-04-01 4/A Currie Mark G CYCN Employee Stock Option (Right to Buy) A - Award D 14,21 514.698 514.698
2019-09-20 2019-04-01 4/A Currie Mark G CYCN Employee Stock Option (Right to Buy) A - Award D 16,02 140.984 140.984
2019-09-20 2019-04-01 4/A Currie Mark G CYCN Employee Stock Option (Right to Buy) A - Award D 18,47 113.413 113.413
2019-09-20 2019-04-01 4/A Currie Mark G CYCN Employee Stock Option (Right to Buy) A - Award D 11,28 50.794 50.794
2019-09-20 2019-04-01 4/A Currie Mark G CYCN Employee Stock Option (Right to Buy) A - Award D 17,20 2.500 2.500
2019-09-20 2019-04-01 4/A Currie Mark G CYCN Employee Stock Option (Right to Buy) A - Award D 14,40 27.772 27.772
2019-09-20 2019-04-01 4/A Currie Mark G CYCN Employee Stock Option (Right to Buy) A - Award D 16,21 17.490 17.490
2019-09-20 2019-04-01 4/A Currie Mark G CYCN Employee Stock Option (Right to Buy) A - Award D 12,24 37.279 37.279
2019-09-20 2019-04-01 4/A Hecht Peter M CYCN Employee Stock Option (Right to Buy) A - Award D 14,21 857.830 857.830
2019-09-20 2019-04-01 4/A Hecht Peter M CYCN Employee Stock Option (Right to Buy) A - Award D 16,02 380.330 380.330
2019-09-20 2019-04-01 4/A Hecht Peter M CYCN Employee Stock Option (Right to Buy) A - Award D 18,47 344.777 344.777
2019-09-20 2019-04-01 4/A Hecht Peter M CYCN Employee Stock Option (Right to Buy) A - Award D 11,28 223.893 223.893
2019-09-20 2019-04-01 4/A Hecht Peter M CYCN Employee Stock Option (Right to Buy) A - Award D 15,54 37.972 37.972
2019-09-20 2019-04-01 4/A Hecht Peter M CYCN Employee Stock Option (Right to Buy) A - Award D 14,40 43.679 43.679
2019-09-20 2019-04-01 4/A Hecht Peter M CYCN Employee Stock Option (Right to Buy) A - Award D 16,21 36.088 36.088
2019-09-20 2019-04-01 4/A Hecht Peter M CYCN Employee Stock Option (Right to Buy) A - Award D 12,24 53.083 53.083
2019-09-20 2019-04-01 4/A Hecht Peter M CYCN Common Stock A - Award D 221.736 221.736
2019-07-12 2019-07-10 4 Hecht Peter M CYCN Employee Stock Option (Right to Buy) M - Exercise D 6,04 -2.000 0
2019-07-12 2019-07-10 4 Hecht Peter M CYCN Common Stock M - Exercise D 6,0400 2.000 12 225.192
2019-06-04 2019-06-01 4 Churchwell Kevin CYCN Stock Option (Right to Buy) A - Award D 13,95 10.000 10.000
2019-06-04 2019-06-01 4 CONRADES GEORGE H CYCN Stock Option (Right to Buy) A - Award D 13,95 10.000 10.000
2019-06-04 2019-06-01 4 Fanucci Marsha CYCN Stock Option (Right to Buy) A - Award D 13,95 10.000 10.000
2019-06-04 2019-06-01 4 Isacson Ole CYCN Stock Option (Right to Buy) A - Award D 13,95 10.000 10.000
2019-06-04 2019-06-01 4 Lovell Stephanie CYCN Stock Option (Right to Buy) A - Award D 13,95 10.000 10.000
2019-06-04 2019-06-01 4 MCGUIRE TERRANCE CYCN Stock Option (Right to Buy) A - Award D 13,95 10.000 10.000
2019-06-04 2019-06-01 4 Mendelsohn Michael CYCN Stock Option (Right to Buy) A - Award D 13,95 10.000 10.000
2019-06-04 2019-06-01 4 SCHULMAN AMY W CYCN Stock Option (Right to Buy) A - Award D 13,95 10.000 10.000
2019-05-01 2019-04-29 4 Busch Andreas CYCN Employee Stock Option (Right to Buy) A - Award D 15,40 300.000 300.000
2019-04-10 2019-04-08 4 SCHULMAN AMY W By Polaris Entrepreneurs' Fund VIII, L.P. CYCN Common Stock P - Purchase I 16,0000 21.635 346 21.635
2019-04-10 2019-04-08 4 SCHULMAN AMY W By Polaris Partners VIII, L.P. CYCN Common Stock P - Purchase I 16,0000 604.482 9.672 604.482
2019-04-10 2019-04-08 4 MCGUIRE TERRANCE By Polaris Entrepreneurs' Fund VIII, L.P. CYCN Common Stock P - Purchase I 16,0000 21.635 346 21.635
2019-04-10 2019-04-08 4 MCGUIRE TERRANCE By Polaris Partners VIII, L.P. CYCN Common Stock P - Purchase I 16,0000 604.482 9.672 604.482
2019-04-04 2019-04-01 4/A CONRADES GEORGE H CYCN Common Stock A - Award D 2.421 4.334
2019-04-03 2019-04-01 4/A Fanucci Marsha CYCN Common Stock A - Award D 3.279 16.950
2019-04-03 2019-04-01 4/A Fanucci Marsha CYCN Common Stock A - Award D 13.671 13.671
2019-04-03 2019-04-01 4 MCGUIRE TERRANCE By Bartlett Partners, L.L.C. CYCN Common Stock A - Award I 6.911 6.911
2019-04-03 2019-04-01 4 MCGUIRE TERRANCE By Polaris Venture Management Co. II, L.L.C. CYCN Common Stock A - Award I 162 162
2019-04-03 2019-04-01 4 MCGUIRE TERRANCE CYCN Common Stock A - Award D 3.279 3.279
2019-04-03 2019-04-01 4 MCGUIRE TERRANCE CYCN Common Stock A - Award D 7.768 7.768
2019-04-03 2019-04-01 4 Hecht Peter M CYCN Employee Stock Option (Right to Buy) A - Award D 14,20 857.977 857.977
2019-04-03 2019-04-01 4 Hecht Peter M CYCN Employee Stock Option (Right to Buy) A - Award D 16,02 380.393 380.393
2019-04-03 2019-04-01 4 Hecht Peter M CYCN Employee Stock Option (Right to Buy) A - Award D 18,46 344.829 344.829
2019-04-03 2019-04-01 4 Hecht Peter M CYCN Employee Stock Option (Right to Buy) A - Award D 11,28 223.919 223.919
2019-04-03 2019-04-01 4 Hecht Peter M CYCN Employee Stock Option (Right to Buy) A - Award D 17,20 56.500 56.500
2019-04-03 2019-04-01 4 Hecht Peter M CYCN Employee Stock Option (Right to Buy) A - Award D 15,54 37.973 37.973
2019-04-03 2019-04-01 4 Hecht Peter M CYCN Employee Stock Option (Right to Buy) A - Award D 14,40 43.680 43.680
2019-04-03 2019-04-01 4 Hecht Peter M CYCN Employee Stock Option (Right to Buy) A - Award D 16,21 36.089 36.089
2019-04-03 2019-04-01 4 Hecht Peter M CYCN Employee Stock Option (Right to Buy) A - Award D 12,23 53.090 53.090
2019-04-03 2019-04-01 4 Hecht Peter M CYCN Employee Stock Option (Right to Buy) A - Award D 12,39 12.499 12.499
2019-04-03 2019-04-01 4 Hecht Peter M CYCN Employee Stock Option (Right to Buy) A - Award D 6,04 2.000 2.000
2019-04-03 2019-04-01 4 Hecht Peter M The 2000 Trust for Zoe Niovi Hecht CYCN Common Stock A - Award I 485 485
2019-04-03 2019-04-01 4 Hecht Peter M The 2000 Trust for Malcolm Paul Hecht CYCN Common Stock A - Award I 485 485
2019-04-03 2019-04-01 4 Hecht Peter M The 2000 Trust for Alexis Mae Hecht CYCN Common Stock A - Award I 485 485
2019-04-03 2019-04-01 4 Hecht Peter M CYCN Common Stock A - Award D 223.192 223.192
2019-04-03 2019-04-01 4 SCHULMAN AMY W CYCN Common Stock A - Award D 3.279 7.508
2019-04-03 2019-04-01 4 SCHULMAN AMY W CYCN Common Stock A - Award D 4.229 4.229
2019-04-03 2019-04-01 4 Huyett William CYCN Employee Stock Option (Right to Buy) A - Award D 14,20 222.002 222.002
2019-04-03 2019-04-01 4 Huyett William CYCN Employee Stock Option (Right to Buy) A - Award D 16,81 221.349 221.349
2019-04-03 2019-04-01 4 Huyett William CYCN Common Stock A - Award D 39.179 78.912
2019-04-03 2019-04-01 4 Huyett William CYCN Common Stock A - Award D 38.327 38.327
2019-04-03 2019-04-02 4 Currie Mark G CYCN Common Stock P - Purchase D 14,8100 270.107 4.000 321.755
2019-04-03 2019-04-01 4 Currie Mark G CYCN Employee Stock Option (Right to Buy) A - Award D 14,20 514.786 514.786
2019-04-03 2019-04-01 4 Currie Mark G CYCN Employee Stock Option (Right to Buy) A - Award D 16,02 141.007 141.007
2019-04-03 2019-04-01 4 Currie Mark G CYCN Employee Stock Option (Right to Buy) A - Award D 18,46 113.430 113.430
2019-04-03 2019-04-01 4 Currie Mark G CYCN Employee Stock Option (Right to Buy) A - Award D 11,28 50.801 50.801
2019-04-03 2019-04-01 4 Currie Mark G CYCN Employee Stock Option (Right to Buy) A - Award D 17,20 2.500 2.500
2019-04-03 2019-04-01 4 Currie Mark G CYCN Employee Stock Option (Right to Buy) A - Award D 17,20 13.125 13.125
2019-04-03 2019-04-01 4 Currie Mark G CYCN Employee Stock Option (Right to Buy) A - Award D 15,54 9.930 9.930
2019-04-03 2019-04-01 4 Currie Mark G CYCN Employee Stock Option (Right to Buy) A - Award D 14,40 27.773 27.773
2019-04-03 2019-04-01 4 Currie Mark G CYCN Employee Stock Option (Right to Buy) A - Award D 16,21 17.491 17.491
2019-04-03 2019-04-01 4 Currie Mark G CYCN Employee Stock Option (Right to Buy) A - Award D 12,23 37.286 37.286
2019-04-03 2019-04-01 4 Currie Mark G CYCN Employee Stock Option (Right to Buy) A - Award D 12,39 888 888
2019-04-03 2019-04-01 4 Currie Mark G CYCN Common Stock A - Award D 51.648 51.648
2019-04-03 2019-04-01 4 Lovell Stephanie CYCN Common Stock A - Award D 2.421 2.421
2019-04-03 2019-04-01 4 Mendelsohn Michael CYCN Common Stock A - Award D 2.421 2.421
2019-04-03 2019-04-01 4 Fanucci Marsha CYCN Common Stock A - Award D 3.279 16.950
2019-04-03 2019-04-01 4 Fanucci Marsha CYCN Common Stock A - Award D 13.671 13.671
2019-04-03 2019-04-01 4 Isacson Ole CYCN Common Stock A - Award D 2.421 2.421
2019-04-03 2019-04-01 4 CONRADES GEORGE H CYCN Common Stock A - Award D 2.421 2.421
2019-04-03 2019-04-01 4 Churchwell Kevin CYCN Common Stock A - Award D 2.421 2.421
2019-04-02 2019-04-01 4 IRONWOOD PHARMACEUTICALS INC CYCN Common Stock J - Other D -15.562.555 0
2019-04-02 2019-03-29 4 IRONWOOD PHARMACEUTICALS INC CYCN Common Stock A - Award D 15.562.455 15.562.555
2019-03-14 3 IRONWOOD PHARMACEUTICALS INC CYCN Common Stock D 200
2019-03-14 3 IRONWOOD PHARMACEUTICALS INC CYCN Common Stock D 200
2019-03-14 3 IRONWOOD PHARMACEUTICALS INC CYCN Common Stock D 200
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista